You just read:

BerGenBio to Present Overview of Phase II Clinical Trial Portfolio Combining Bemcentinib With KEYTRUDA at 3rd Annual Immuno-Oncology Summit Europe

News provided by

BerGenBio ASA

22 Mar, 2018, 07:27 GMT